HCPCS Codes - Medical Procedures, Supplies & DME Codes - q5 Codes
HCPCS Procedure, Supply & DME (Durable Medical Equipment) Codes ("q5" Codes):- Q5001 hospice care provided patients homeresidence HCPCS Code Code
- Q5002 hospice care provided assisted living facility HCPCS Code Code
- Q5003 hospice care provided nursing long term HCPCS Code Code
- Q5004 hospice care provided skilled nursing facility HCPCS Code Code
- Q5005 hospice care provided inpatient hospital HCPCS Code Code
- Q5006 hospice care provided inpatient hospice facility HCPCS Code Code
- Q5007 hospice care provided long term care HCPCS Code Code
- Q5008 hospice care provided inpatient psychiatric facility HCPCS Code Code
- Q5009 hospice care provided place not otherwise HCPCS Code Code
- Q5010 HOSPICE HOME CARE PROVIDED IN A HOSPICE FACILITY HCPCS Code Code
- Q5101 Injection, filgrastim (g-csf), biosimilar, 1 microgram HCPCS Code Code
- Q5102 Injection, Infliximab, Biosimilar, 10 mg HCPCS Code Code
- Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg HCPCS Code Code
- Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg HCPCS Code Code
- Q5105 Injection, epoetin alfa, biosimilar, (Retacrit) (for esrd on dialysis), 100 units HCPCS Code Code
- Q5106 Injection, epoetin alfa, biosimilar, (Retacrit) (for non-esrd use), 1000 units HCPCS Code Code
- Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg HCPCS Code Code
- Q5108 Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg HCPCS Code Code
- Q5109 Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg HCPCS Code Code
- Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram HCPCS Code Code
- Q5111 Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg HCPCS Code Code
- Q5112 Injection, trastuzumab-dttb, biosimilar, (Ontruzant), 10 mg HCPCS Code Code
- Q5113 Injection, trastuzumab-pkrb, biosimilar, (Herzuma), 10 mg HCPCS Code Code
- Q5114 Injection, Trastuzumab-dkst, biosimilar, (Ogivri), 10 mg HCPCS Code Code
- Q5115 Injection, rituximab-abbs, biosimilar, (Truxima), 10 mg HCPCS Code Code
- Q5116 Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg HCPCS Code Code
- Q5117 Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg HCPCS Code Code
- Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg HCPCS Code Code
- Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg HCPCS Code Code
- Q5120 Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg HCPCS Code Code
- Q5121 Injection, infliximab-axxq, biosimilar, (avsola), 10 mg HCPCS Code Code
- Q5122 Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg HCPCS Code Code
- Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg HCPCS Code Code
- Q5124 Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg HCPCS Code Code
- Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram HCPCS Code Code
- Q5126 Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg HCPCS Code Code
- Q5127 Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg HCPCS Code Code
- Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg HCPCS Code Code
- Q5129 Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg HCPCS Code Code
- Q5130 Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg HCPCS Code Code
- Q5131 Injection, adalimumab-aacf (idacio), biosimilar, 20 mg HCPCS Code Code
- Q5132 Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg HCPCS Code Code
- Q5133 Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg HCPCS Code Code
- Q5134 Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg HCPCS Code Code
- Q5137 Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg HCPCS Code Code
- Q5138 Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg HCPCS Code Code
Back to list of HCPCS Procedure, Supply & DME Codes
HCPCS Medical Codes & Code Modifiers
(HCPCS is commonly pronounced Hick-Picks.)Each year, in the United States, health care insurers process over 5 billion claims for payment. For Medicare and other health insurance programs to ensure that these claims are processed in an orderly and consistent manner, standardized coding systems are essential. The HCPCS Level II Code Set is one of the standard code sets used for this purpose. The HCPCS is divided into two principal subsystems, referred to as level I and level II of the HCPCS. Level I of the HCPCS is comprised of CPT (Current Procedural Terminology), a numeric coding system maintained by the American Medical Association (AMA). The CPT is a uniform coding system consisting of descriptive terms and identifying codes that are used primarily to identify medical services and procedures furnished by physicians and other health care professionals. These health care professionals use the CPT to identify services and procedures for which they bill public or private health insurance programs. Decisions regarding the addition, deletion, or revision of CPT codes are made by the AMA. The CPT codes are republished and updated annually by the AMA. Level I of the HCPCS, the CPT codes, does not include codes needed to separately report medical items or services that are regularly billed by suppliers other than physicians.
Level II of the HCPCS is a standardized coding system that is used primarily to identify products, supplies, and services not included in the CPT codes, such as ambulance services and durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) when used outside a physician's office. Because Medicare and other insurers cover a variety of services, supplies, and equipment that are not identified by CPT codes, the level II HCPCS codes were established for submitting claims for these items. The development and use of level II of the HCPCS began in the 1980's. Level II codes are also referred to as alpha-numeric codes because they consist of a single alphabetical letter followed by 4 numeric digits, while CPT codes are identified using 5 numeric digits.
In October of 2003, the Secretary of HHS delegated authority under the HIPAA legislation to CMS to maintain and distribute HCPCS Level II Codes. As stated in 42 CFR Sec. 414.40 (a) CMS establishes uniform national definitions of services, codes to represent services, and payment modifiers to the codes. Within CMS there is a CMS HCPCS Workgroup which is an internal workgroup comprised of representatives of the major components of CMS, as well as other consultants from pertinent Federal agencies. Prior to December 31, 2003, Level III HCPCS were developed and used by Medicaid State agencies, Medicare contractors, and private insurers in their specific programs or local areas of jurisdiction. For purposes of Medicare, level III codes were also referred to as local codes. Local codes were established when an insurer preferred that suppliers use a local code to identify a service, for which there is no level I or level II code, rather than use a "miscellaneous or not otherwise classified code." The Health Insurance Portability and Accountability Act of 1996 (HIPAA) required CMS to adopt standards for coding systems that are used for reporting health care transactions. We published, in the Federal Register on August 17, 2000 (65 FR 50312), regulations to implement this part of the HIPAA legislation. These regulations provided for the elimination of level III local codes by October 2002, at which time, the level I and level II code sets could be used. The elimination of local codes was postponed, as a result of section 532(a) of BIPA, which continued the use of local codes through December 31, 2003.
(Source: http://www.cms.hhs.gov/MedHCPCSGenInfo/)
Thank you for choosing Find-A-Code, please Sign In to remove ads.